|
 Home: PCU
3|2003:
FACULTY DISCLOSURES
As a provider accredited by the ACCME, it is the policy of NL
Communications to require the disclosure of any significant financial
interest or any other relationship the sponsor or faculty members
have with the manufacturer(s) of any commercial product(s) discussed
in an educational presentation.
| Laurence Klotz,
MD, FRCSC |
Grants/Research Support: Abbott
Laboratories
Consultant: Novartis Pharmaceuticals Corporation
Speakers' Bureau: AstraZeneca Pharmaceuticals
LP,
Aventis Pharmaceuticals, Inc |
| Paul F Schellhammer, MD |
Grants/Research Support: AstraZeneca Pharmaceuticals
LP Consultant: Schering-Plough Corporation Stockholder: Abbott
Laboratories Speakers' Bureau: Dendreon Corporation |
| Anthony L Zeitman, MD,
FRCR |
No financial interests or affiliations to disclose. |
This educational activity contains discussion of published and/or
investigational uses of agents that are not indicated by the FDA.
NL Communications, Inc does not recommend the use of any agent
outside of the labeled indications. Please refer to the official
prescribing information for each product for discussion of approved
indications, contraindications and warnings. The opinions expressed
are those of the presenters and are not to be construed as those
of the publisher or grantor.
|
|
